NCT07262567 2025-12-03
Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
Genfleet Therapeutics (Shanghai) Inc.
Phase 3 Not yet recruiting
Genfleet Therapeutics (Shanghai) Inc.
The First Affiliated Hospital with Nanjing Medical University
National Health Research Institutes, Taiwan
Lee's Pharmaceutical Limited
Royal Marsden NHS Foundation Trust